This program honors and celebrates the accomplishments of leading researchers and educators whose discoveries have propelled the field and set the groundwork for future advancements.
Learn about new Ruesch faculty led GI cancer research, advocacy events, and patient community-building initiatives.
John Marshall, MD, defined the focus for the scientific briefing portion of this year’s symposium: young people getting GI cancers at an alarming rate.
One of the most meaningful gifts you can give cancer patients and their families is hope.
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Caring for the whole person: Learn how a multi-disciplinary approach drives patient-centered care at The Ruesch Center for the Cure of Gastrointestinal Cancers
National Cancer Institute Renews Georgetown Lombardi Top Designation
May 2nd, 2024
The National Cancer Institute (NCI), a part of the National Institutes of Health, has awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown University‘s Lombardi Comprehensive Cancer Center in recognition of its high-impact research, community outreach and cancer care…
Dr. John Marshall Inducted into Giants of Cancer Care
May 2nd, 2024
This program honors and celebrates the accomplishments of leading researchers and educators whose discoveries have propelled the field and set the groundwork for future advancements.…
Treating Colorectal Cancer: Overview of MRD Testing and ctDNA
March 20th, 2024
Dr. Marshall and Dr. Weinberg and other oncologists, provide an overview of circulating tumor DNA and its role in MRD (minimal residual disease) testing in the treatment of patients with colorectal cancer.…
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver information on upcoming educational events, current clinical trials, and cutting-edge research and trends in the GI cancer field.
